INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenue, net | 415,605 | 382,653 | 380,834 | |
| Selling, general and administrative | 179,890 | 181,497 | 177,193 | |
| Research and development | 26,997 | 24,728 | 27,435 | |
| Goodwill impairment charge | 511,365 | - | - | |
| Cost of goods sold | 206,273 | 188,221 | 180,596 | |
| Intangible asset amortization | 3,754 | 3,704 | 3,760 | |
| Total costs and expenses | 928,279 | 398,150 | 388,984 | |
| Operating (loss) income | -512,674 | -15,497 | -8,150 | |
| Interest income | 4,710 | 4,420 | 5,049 | |
| Interest expense | 21,042 | 18,815 | 19,373 | |
| Other (expense) income, net | -1,946 | -144 | 2,112 | |
| Loss before income taxes | -530,952 | -30,036 | -20,362 | |
| Benefit for income taxes | -46,879 | -4,743 | -9,667 | |
| Net loss | -484,073 | -25,293 | -10,695 | |
| Basic (in dollars per share) | -6.31 | -0.33 | -0.14 | |
| Basic (in shares) | 76,695,000 | 76,463,000 | 76,448,000 | |
| Diluted (in dollars per share) | -6.31 | -0.33 | -0.14 | |
| Diluted (in shares) | 76,695,000 | 76,463,000 | 76,448,000 | |